Tricyclic inhibitors of poly(ADP-ribose) polymerases
Compounds of the formula below are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease. As cancer therapeutics, the compounds of the invention may be used, e.g...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
12.01.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!